GlassScriptPhysician profile
Zachary Perkins
NPI 1326614934
$822.09
in general payments reported to CMS, 2019-2025
11 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $38.59 · 2022: $217 · 2023: $300 · 2024: $149 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $566.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $238.43 | 2022-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $141.97 | 2022-2024 | Lifevest |
| Abiomed | $116.10 | 2024 | Impella |
| Merck Sharp & Dohme LLC | $109.90 | 2022-2023 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $55.02 | 2023 | |
| Novartis Pharmaceuticals Corporation | $43.12 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.90 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $27.04 | 2022 | |
| Boston Scientific Corporation | $21.64 | 2022 | |
| Pfizer INC. | $16.90 | 2022 | |
| Lantheus Medical Imaging, INC. | $13.07 | 2023 | Definity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachary Perkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.